Impact Factor 5.091 | CiteScore 4.1
More on impact ›
The rheumatology specialty section of Frontiers in Medicine publishes the latest insights in the mechanisms of disease, new biomarkers, clinical epidemiology and new treatment perspectives of rheumatic diseases, with the aim of helping clinical rheumatologists to achieve better patient’s individual outcomes. We also aim at promoting basic, translational and clinical research, engaging clinicians and scientist in the common goal of expanding the rheumatology frontiers of knowledge.
In the past few decades, we witnessed a revolution in the care of patients with rheumatic conditions. A better understanding of the physiopathology of this heterogeneous group of diseases paved the way for novel treatments and more aggressive treatment strategies. Particularly for inflammatory rheumatic diseases, remission became the treatment goal. Nevertheless, most patients with chronic joint inflammatory conditions still suffer from a disease that is debilitating and unremitting, as only few patients attain sustained remission. In addition, pathologies such as scleroderma and osteoarthritis still lack true disease-modifying treatments. Finally, the management of common diseases, such as osteoporosis, back pain and periarticular soft tissue conditions, remains an open field for the development of new evidence-based treatment strategies. Therefore, despite noticeable progress, rheumatology is still a medical area with many ongoing challenges.
Contrary to other fields of medicine, such as cardiology or oncology, early diagnostic and prognostic markers and predictors of treatment response are lacking in rheumatology. Stratification of patients and treatment profiling remains distant from rheumatology daily practice. Rheumatology has to find its way through various aspects of research that would lead to the eventual adaptation of a precision medicine approach for treating patients with rheumatic disorders.
The rheumatology specialty section of Frontiers in Medicine publishes the latest insights in the mechanisms of disease, new biomarkers, clinical epidemiology and new treatment perspectives of rheumatic diseases, with the aim of helping clinical rheumatologists to achieve better patients’ individual outcomes. We also promote basic, translational and clinical research, engaging clinicians and scientists in the common goal of expanding the frontiers of knowledge in rheumatology.
Indexed in: CLOCKSS, DOAJ, Google Scholar, PubMed, PubMed Central (PMC), Scopus
PMCID: all published articles receive a PMCID
Rheumatology welcomes submissions of the following article types: Brief Research Report, Case Report, Clinical Trial, Correction, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Original Research, Perspective, Review, Study Protocol and Systematic Review.
All manuscripts must be submitted directly to the section Rheumatology, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact email@example.com
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact firstname.lastname@example.org